RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Breye Therapeutics

Breye Therapeutics

Breye Therapeutics develops oral medicines for retinal diseases, with a focus on diabetic retinopathy and age-related macular degeneration.

Latest funding

$76.65M Series A ·

Led by Mission BioCapital · Source: european-biotechnology.com

Total raised: $80.77M across 2 sourced rounds

All 2 rounds ↓
Website: breye.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biopharma, Biotechnology, Life Science, Medical, Pharmaceutical.
Stage: Series A.
Based in: Hørsholm, Denmark.
Founded: 2022.
Total raised: $80.77M in 2 sourced rounds.
Last round: Sep 29, 2026 · 50 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 4, 2026.

Signals

Website registeredMay 4, 2005 (21 years old)

Funding rounds

DateRoundAmountLeadSource
Series A$76.65MMMission BioCapitaleuropean-biotechnology.com
Seed$4.12MNNovo Holdingsfinsmes.com

Timeline

  1. Website created

Founders and team

Investors

Companies like Breye Therapeutics

Other companies backed by Mission BioCapital

Mission BioCapital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/breye-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy